Design of tuneable, biocompatible anionic polymers by l-norvaline amino acid post-polymerisation modification of pentafluorophenyl acrylate copolymers

Titelangaben

Ringleb, Michael ; Streiber, Michael ; Lutz, Theresa M. ; Rother, Lena ; Bachinger, Elisa-Maria ; De Breuck, Jonas ; Künneth, Christopher ; Schubert, Ulrich S. ; Zechel, Stefan ; Traeger, Anja ; Leiske, Meike N.:
Design of tuneable, biocompatible anionic polymers by l-norvaline amino acid post-polymerisation modification of pentafluorophenyl acrylate copolymers.
In: RSC Applied Polymers. Bd. 4 (2026) Heft 3 . - S. 964-983.
ISSN 2755-371X
DOI: https://doi.org/10.1039/d5lp00376h

Angaben zu Projekten

Abstract

Based on their high cytocompatibility and unique interactions with biological matter, polyanions are attracting increasing research interest. The hydrophilicity–hydrophobicity ratio of these substances exerts a significant influence on their applicability as delivery systems, i.e., for particle formation and their interaction with biological matter. In this study a library of anionic copolymers with tailored hydrophilicity–hydrophobicity ratio is generated: First, random copolymers of pentafluorophenyl acrylate (PFPA) and hydrophilic N-acryloylmorpholine (NAM) or hydrophobic methyl acrylate (MA), respectively, are synthesised. In a second step, the PFPA units are substituted by l-norvaline (Nva) via post-polymerisation modification. We found that the comonomer ratio within the polymer has an impact on the hydrophobicity of the copolymers – in particular the Nva moiety significantly influences the hydrophobicity. Moreover, all investigated polymers feature good biocompatibility, while an increase in NAM content only slightly affects the hemolytic activity. Furthermore, an exemplary tested NAM-copolymer shows fast intracellular uptake in just 4 h. Our results obtained with Nva modified copolymers of different hydrophobicity-hydrophilicity ratio indicate that those polyanions could have potential for further biomedical applications such as drug delivery.